2‐Phenyl‐imidazo[1,2‐a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats
Open Access
- 1 May 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (1) , 177-187
- https://doi.org/10.1038/sj.bjp.0702530
Abstract
Selective activation of peripheral benzodiazepine receptors (PBRs) in adrenal cells and brain oligodendrocytes promotes steroidogenesis. Three 2‐phenyl‐imidazo[1,2‐a]pyridine derivatives (CB 34, CB 50 and CB 54) have now been investigated with regard to their selectivity for PBRs and their ability to stimulate central and peripheral steroidogenesis in rats. The three CB compounds (10−10–10−4 M) potently inhibited the binding of the PBR ligand [3H]‐PK 11195 to brain and ovary membranes in vitro, without substantially affecting [3H]‐flunitrazepam binding to central benzodiazepine receptors. These compounds (10−7–10−4 M) also had little or no marked effects on GABA‐evoked Cl− currents in voltage‐clamped Xenopus oocytes expressing human α1β2γ2S GABAA receptors. In addition, they failed to affect ligands binding to GABAB, D1/D2 dopamine, muscarinic acetylcholine, N‐methyl‐D‐aspartic acid and opiate receptors. Intraperitoneal administration of CB compounds (3–50 mg kg−1) induced a dose‐dependent increase in the concentrations of neuroactive steroids in plasma and brain. The brain concentrations of pregnenolone, progesterone, allopregnanolone and allotetrahydrodeoxycorticosterone (THDOC) showed maximal increases in 96±3, 126±14, 110±12 and 70±13% above control, respectively, 30 to 60 min after injection of CB 34 (25 mg kg−1). CB 34 also increased the brain concentrations of neuroactive steroids in adrenalectomized‐orchiectomized rats, although to a lesser extent than in sham‐operated animals, suggesting that CB compounds stimulate brain steroidogenesis independently of their effects on peripheral tissues. The increase in brain and plasma neurosteroid content induced by CB 34 was associated with a marked anticonflict effect in the Vogel test. Our results indicate that the three CB compounds tested are specific and potent agonists at peripheral benzodiazepine receptors, and that they stimulate steroidogenesis in both the brain and periphery. British Journal of Pharmacology (1999) 127, 177–187; doi:10.1038/sj.bjp.0702530Keywords
This publication has 47 references indexed in Scilit:
- Calmidazolium and other imidazole compounds affect steroidogenesis in Y1 cells: Lack of involvement of the peripheral-type benzodiazepine receptorThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanoloneJournal of Psychopharmacology, 1996
- Stimulation of Brain Pregnenolone Synthesis by Mitochondrial Diazepam Binding Inhibitor Receptor Ligands In VivoJournal of Neurochemistry, 1993
- Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptorBrain Research, 1991
- Neurosteroids: a new function in the brainBiology of the Cell, 1991
- Neurosteroids act on recombinant human GABAA receptorsNeuron, 1990
- Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA ReceptorScience, 1986
- In vivo secretion of 3α-hydroxy-5α-pregnan-20-one, a potent anaesthetic steroid, by the adrenal gland of the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, R05–4864, of the peripheral benzodiazepine receptorsLife Sciences, 1984
- Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamideLife Sciences, 1983